05:35 PM EDT, 08/05/2025 (MT Newswires) -- Eugene Schneider, Executive Vice President, Chief Clinical Development and Operations Officer, on August 04, 2025, sold 9,549 shares in Ionis Pharmaceuticals ( IONS ) for $408,701. Following the Form 4 filing with the SEC, Schneider has control over a total of 51,507 common shares of the company, with 51,507 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/874015/000087401525000172/xslF345X05/edgardoc.xml